University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

Simple item page
dc.contributor.authorBraude, Philip
dc.contributor.authorCarter, Ben
dc.contributor.authorShort, Roxanna
dc.contributor.authorVilches-Moraga, Arturo
dc.contributor.authorVerduri, Alessia
dc.contributor.authorLyndsay Pearce, Miss
dc.contributor.authorAngeline Price, Miss
dc.contributor.authorQuinn, Terence J
dc.contributor.authorStechman, Michael
dc.contributor.authorCollins, Jemima
dc.contributor.authorBruce, Eilidh
dc.contributor.authorEinarsson, Alice
dc.contributor.authorRickard, Frances
dc.contributor.authorMitchell, Emma
dc.contributor.authorHolloway, Mark
dc.contributor.authorHesford, James
dc.contributor.authorBarlow-Pay, Fenella
dc.contributor.authorClini, Enrico
dc.contributor.authorKyaw Myint, Phyo
dc.contributor.authorMoug, Susan
dc.contributor.authorMcCarthy, Kathryn
dc.contributor.authorHewitt, Jonathan
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2021-12-06T14:49:01Z
dc.date.available2021-12-06T14:49:01Z
dc.date.issued2020-12-01
dc.description.statusPeer revieweden
dc.format.extent7
dc.format.extent310902
dc.identifier177469695
dc.identifier870df26f-0bb1-4f6d-a5f9-e4d20e3c4581
dc.identifier33083516
dc.identifier33083516
dc.identifier85094813576
dc.identifier.citationBraude, P, Carter, B, Short, R, Vilches-Moraga, A, Verduri, A, Lyndsay Pearce, M, Angeline Price, M, Quinn, T J, Stechman, M, Collins, J, Bruce, E, Einarsson, A, Rickard, F, Mitchell, E, Holloway, M, Hesford, J, Barlow-Pay, F, Clini, E, Kyaw Myint, P, Moug, S, McCarthy, K & Hewitt, J 2020, 'The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19', IJC Heart & Vasculature, vol. 31, 100660. https://doi.org/10.1016/j.ijcha.2020.100660en
dc.identifier.doi10.1016/j.ijcha.2020.100660
dc.identifier.issn2352-9067
dc.identifier.otherPubMedCentral: PMC7561344
dc.identifier.otherORCID: /0000-0003-3852-6158/work/163198801
dc.identifier.urihttps://hdl.handle.net/2164/17622
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85094813576&partnerID=8YFLogxKen
dc.identifier.vol31en
dc.language.isoeng
dc.relation.ispartofIJC Heart & Vasculatureen
dc.subjectCoronavirusen
dc.subjectAngiotensin receptor antagonistsen
dc.subjectangiotensin-converting enzyme inhibitorsen
dc.subjecthospitalizationen
dc.subjecthospital mortalityen
dc.subjectAngiotensin-converting enzyme inhibitorsen
dc.subjectHospital mortalityen
dc.subjectHospitalizationen
dc.subjectR Medicineen
dc.subjectCardiology and Cardiovascular Medicineen
dc.subjectSupplementary Dataen
dc.subjecthttps://doi.org/10.1016/j.ijcha.2020.100660en
dc.subject.lccRen
dc.titleThe influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Braude_etal_IJCHV_influence_of_ACE_inhibitors_VOR.pdf
Size:
303.62 KB
Format:
Adobe Portable Document Format
Download

Collections

All research